Category Archives: Cancer Research

Oncotarget: Leading Oncology Publication

The science of oncology deals with cancer, its symptoms, diagnosis, and treatment. It is one of the most common diseases to be acquired by humans, and it is also incurable. For years, scientists have done experiments on how they can find the cure for the disease. According to scientists, it will still be a long way before they can find a treatment for cancer. Mikhail Blagosklonny and Andrei Gudkov joined together to create an online medical journal, and they explained that the objective why they are putting it online is because they wanted the scientists around the world to work together and formulate a cure for cancer. The two are colleagues at the Roswell Park Cancer Institute, where they work together as oncologists. Listen to an audio podcast of Oncotarget on Itunes.


Mikhail Blagosklonny and Andrei Gudkov found out that there are only a few articles online dealing with oncology. He wanted to create a system that would allow other scientists from around the globe to send their written articles about the disease. Mikhail Blagosklonny and Andrei Gudkov as the publication’s editors in chief will be reviewing the papers submitted to them and determine whether it is acceptable to be published or not. Often, there is a panel of scientists who would be considering the article. It is known as the first peer review online medical journal, and the scientist aims to make sure that all of the data presented are factual. Listen to Oncotarget podcast on Player.FM.

Established in 2010, Oncotarget was initially released to the public once every week. However, after receiving a positive reception from the readers, Oncotarget decided to publish a new article twice every week. These scientific articles will be reviewed by scientists, and when approved, it will appear on the online medical journal portal. Scientists have thanked Mikhail Blagosklonny and Andrei Gudkov for their outstanding invention. They revealed that the introduction of Oncotarget would soon change a lot of lives. Meanwhile, Mikhail Blagosklonny and Andrei Gudkov are optimistic that Oncotarget will become an instrument in the future that will help humans exterminate fatal disease and gain closer to immortality. Mikhail Blagosklonny and Andrei Gudkov are promoting the online medical journal to other people who have not seen it and telling them that they could learn a lot just by reading it.

Read more:

Clay Siegall Joins Hands with Other Researchers In Improving Cancer Treatment And Diagnosis

The recent research carried out about cancer has revealed very alarming statistics that 40% of people living in the world are likely to be diagnosed with cancer during their lifetime. Further findings showed that 600,000 cancer patients succumb to death in America every year, while an approximate 1.6 million people are diagnosed with cancer in the same country every year. By 2014, approximately 14.5 million of America’s population were living with cancer.

While these are the sad news glaring at the world, innovative research about cancer treatment and diagnosis are daily being conducted, with dedicated people like Dr. Clay Siegall being in the front line. IN his Company, Seattle Genetics, a cancer research center, a series of serious research about targeted cancer therapies has been taking place. His company was the first to develop antibody-drug conjugate, ADC, which is currently one of the most promising cancer treatment methods.

Dr. Clay having studied zoology at Maryland University as his undergraduate degree and holds a Ph.D. in genetics from George Washington University, he has a deep understanding of the human genes. The human body has about 20,000 genes of which most are in a healthy state. However, at some point some of these genes may develop errors, though some of these errors may be harmless, some may be a danger indicator of cancer have a chance of developing in future.

More Improvements in Cancer Diagnosis

In a recent directive from Prof Dame Sally from England, the National Health Service is supposed to start doing DNA tests on cancer patients, for easy detection of the effective treatment of the patient. Through the use of WGS, comparison of the cancerous cells and the normal cells are able to reveal errors in a patient’s genetic code, something that will help give a more customized treatment., than the normal Chemotherapy and radiotherapy, which may sometimes fail.

In another research in the University of Lyon in France, simple urine tests are being used to estimate the chances of bladder cancer recurring in a patient. The presence of TERT, which is a faulty protein indicated that recurrence is likely to happen 80% of the times.

All these improvements and more specific tests are a great hope in the battle against cancer. While more scientists, researchers, and donors are doing more day and night to see the current statistics are reverted in future.